Teratogenic effects of 6-aminonicotinamide in mice.

J Toxicol Environ Health

Published: November 1977

6-Aminonicotinamide (6-AN), a potential broad-spectrum rodenticide, was examined for embryotoxic and teratogenic potential. Mice of the BALB/c strain were given a single oral dose of 1, 17, 34, 51 or 136 mg/kg on one of days 8 to 13 of gestation. Fetuses were either examined on day 18 post coitum (prenatal study), or allowed to go to term and examined 2 days after birth. Dam weights were significantly reduced (p less than 0.01) at dose levels of 17 mg/kg and greater. These same dose levels caused a significant decrease (p less than 0.01) in litter size and in mean fetal weight. They also caused an increase in the number of resorptions. Hydrocephalus and cleft palate were the most frequent visceral anomalies and were dose-dependent. Skeletal anomalies were also dose-dependent, and the fetus was most susceptible on days 8 to 10 post coitum. A significant (p less than 0.05) increase in the ratio of female to male fetuses was observed at dose levels of 34 mg/kg and greater. Surviving 2-day-old pups had few visceral anomalies but skeletal anomalies were more frequent. Because of its teratogenic properties, it would be difficult to register 6-AN for use against commensal rodents or as a broad-spectrum rodenticide for use in agricultural crops.

Download full-text PDF

Source
http://dx.doi.org/10.1080/15287397709529608DOI Listing

Publication Analysis

Top Keywords

dose levels
12
broad-spectrum rodenticide
8
post coitum
8
levels mg/kg
8
mg/kg greater
8
visceral anomalies
8
anomalies dose-dependent
8
skeletal anomalies
8
teratogenic effects
4
effects 6-aminonicotinamide
4

Similar Publications

Pharmacokinetics of Nivolumab and Erythropoietin in a Rat Model of Diet-Induced Obesity.

Pharm Res

January 2025

Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ, 08854, USA.

Purpose: To investigate how obesity affects the pharmacokinetics of biologics in a rat model.

Method: Male Long-Evans rats were fed a high-fat diet from the age of 3 weeks and development of obesity was monitored by measuring body size and composition (fat and lean mass). The animals received nivolumab (1 and 8 mg/kg) or recombinant human erythropoietin (rHuEPO, 1000 IU/kg) by intravenous or subcutaneous injection.

View Article and Find Full Text PDF

Lithium compromises the bioenergetic reserve of cardiomyoblasts mitochondria.

J Bioenerg Biomembr

January 2025

Institute of Molecular Physiology and Genetics, Centre of Biosciences of the Slovak Academy of Sciences, Dubravska cesta 9, Bratislava, 840 05, Slovakia.

Lithium is used in the long-term treatment of bipolar disorder, exhibiting a beneficial effect on the neuronal cells. The concentration of lithium in the blood serum can vary and can easily approach a level that is related to cardiotoxic adverse effects. This is due to its narrow therapeutic index.

View Article and Find Full Text PDF

The opioid crisis, driven by synthetic opioids like fentanyl, demands innovative solutions. The opioid antidote naloxone has a short action ( ~ 1 hour), requiring repeated doses. To address this, we present a new and simple naloxone prodrug delivery system repurposing a hydrophilic derivative of acoramidis, a potent transthyretin ligand.

View Article and Find Full Text PDF

[Artificial light at night effects glucose metabolism in the developing jawbone by inhibiting melatonin secretion].

Zhonghua Kou Qiang Yi Xue Za Zhi

January 2025

Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology & School of Stomatology, Tongji Medical College, Huazhong University of Science and Technology & Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, Wuhan 430022, China.

To investigate the effects of artificial light at night on the growth of mandibles in mice and its regulatory mechanisms. A mouse model of artificial light at night (night light pollution group) and normal lighting (normal light group) was established by controlling light exposure time, with 4 mice in each group. Micro-CT was employed to analyze the differences in bone quantities of the mandibles between the two groups.

View Article and Find Full Text PDF

Radiopharmaceuticals targeting prostate-specific membrane antigen (PSMA) have emerged as a sensitive tool for PET imaging of prostate cancer (PCa) recurrence. Yet urinary bladder activity may obscure the visualization of prostate bed recurrence. Among the Food and Drug Administration-approved PSMA radiopharmaceuticals, F-flotufolastat (rhPSMA-7.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!